Reportedly, Tesla (TSLA) is set to suspend Model Y assembly between December 25 and January 1 at its Shanghai plant. The suspension at the end of the month is reportedly a part of a reduction in planned production of about 30% in the month for the Model Y, Tesla’s best-selling model, at China’s Shanghai factory. The Shanghai factory, which is the most important manufacturing hub for Tesla maintained normal operations last year during December.
The EV giant is aiming production of just over 20,000 Model Y vehicles for the combined last three weeks of December, including the week of suspended output.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.
DID YOU KNOW?
China’s infertility rate increasing at faster-than-expected rate. Read more At:
https://www.aninews.in/news/world/asia/chinas-infertility-rate-increasing-at-faster-than-expected-rate-says-expert20210618164300/
If you have ever struggled with infertility issues, or know someone who has, you are probably well aware of how demoralizing it can be. Imagine for a moment spending thousands of dollars and months of intensive medical procedure only to end up empty handed, exhausted, sad, and defeated because after all of that time, work, and money, you still don’t have a baby. That’s an incredibly difficult situation, and it’s becoming more common each passing year. Likewise, the need for more effective, less invasive infertility treatment options is increasing with each passing year. This is the sole focus of medtech company INVO Bioscience (NASDAQ: INVO). Learn more by reading the following story that we published recently.
